PGD is performed as a part of an In Vitro Fertilization cycle where multiple eggs are produced, retrieved from the ovaries and fertilized with the partner's sperm in the Embryology Laboratory. IVF gives us access to embryo(s) in vitro. PGD is then performed by removing one or two cells from each embryo through a procedure called embryo biopsy. These cells are analyzed in the RMA Genetics Laboratory for the presence of genetic disorders and chromosomal abnormalities. This sophisticated and technologically advanced testing attempts to identify embryos which are free of abnormalities and more able to achieve the patient's goal of a healthy baby.
PGD technology IDENTIFIES GENETIC ABNORMALITIES IN EMBRYOS
Chromosomal abnormalities in early embryonic cells are analyzed in The RMA Genetics Laboratory by fluorescence in situ hybridization (FISH) to determine proper structure and the appropriate number of the chromosomes tested. Inherited Single Gene Disorders are analyzed in collaboration with a contracted laboratory.

1. PGD & INFERTILITY
  • Recurrent Pregnancy Loss
  • Advanced Maternal Age
  • Male Infertility
  • Repeated IVF Failure


    • 2. STRUCTURAL ABNORMALITIES
  • Translocations
  • Inversions
  • Deletions


    • 3. INHERITED SINGLE-GENE DISORDERS

    Our State of the Art Laboratory offers several testing panels analyzing up to nine chromosomes (13, 15, 16, 17, 18, 21, 22, XY). These panels can be tailored to your center's embryo transfer protocol timetables. New tests are developing daily; please discuss the availability of testing panels with our Laboratory Director.

    RMA Genetics is pleased to work with our colleagues throughout the United States to offer:
  • Genetic counseling
  • Training on blastomere biopsy and fixation at no charge
  • Facilitate full biopsy and/or fixation by highly trained per diem embryologists

    		•